CHANTIX- varenicline tartrate kit United States - English - NLM (National Library of Medicine)

chantix- varenicline tartrate kit

proficient rx lp - varenicline tartrate (unii: 82269asb48) (varenicline - unii:w6hs99o8zo) - varenicline 0.5 mg - chantix is indicated for use as an aid to smoking cessation treatment. chantix is contraindicated in patients with a known history of serious hypersensitivity reactions or skin reactions to chantix. pregnancy category c. there are no adequate and well-controlled studies of chantix use in pregnant women. in animal studies, chantix caused decreased fetal weights, increased auditory startle response, and decreased fertility in offspring. chantix should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. in reproductive and developmental toxicity studies, pregnant rats and rabbits received varenicline succinate during organogenesis at oral doses up to 15 and 30 mg/kg/day, respectively. these exposures were 36 (rats) and 50 (rabbits) times the human exposure (based on auc) at the maximum recommended human dose (mrhd) of 1 mg twice daily. while no fetal structural abnormalities occurred in either species, reduced fetal weights occurred in rabbits at the highest dose (

RHOPHYLAC 300 Israel - English - Ministry of Health

rhophylac 300

csl behring ltd., israel - anti-d immunoglobulins - solution for injection - anti-d immunoglobulins 150 mcg/ml - anti-d (rh) immunoglobulin - anti-d (rh) immunoglobulin - prophylaxis of rh (d) immunisation in rh (d)-negative women: anti-d immune globulin is administered for the prevention of rh (d) immunization if it has been demonstrated or if it is suspected that fetal erythrocytes have entered the circulation of the mother. treatment is not necessary when it is assured that the child or the father are rh (d)- negative. criteria for a rhesus-incompatible pregnancy and the administration of anti-d immune globulin are : a) the mother is rh (d) -negative b) the child is either rh (d)-positive rh (d)weak - positive or its rhesus type is not known. routine antepartum prophylaxis : to prevent rh (d) immunisation due to spontaneous fetomaternal haemorrhage (fmh) during the last trimester of pregnancy. postpartum prophylaxis to prevent rh (d) immunisation of the rh (d)-negative mother following delivery of a rh (d)-positive child. complications of pregnancy: interventions during pregnancy such as invasive prenatal diagnosis (e.g. amniocentesis chorionic villus sampling fetal blood sampling) or other intrauterine procedures (e.g. insertion of shunts embryo reduction) external version of the fetus and therapeutic abortion. incidents during pregnancy such as antepartum haemorrhage spontaneous abortion ruptured tubal pregnancy ectopic pregnancy stillbirths intrauterine death and abdominal trauma. treatment of rh (d) -negative persons after incompatible transfusions of rh (d)-positive blood or erythrocyte concentrate: prevention of rh (d) immunisation in rh (d)-negative persons who for any reason have been given blood or blood components containing rh (d)-positive red cells.

RHOPHYLAC 1500IU human anti-D immunoglobulin solution for injection syringe Australia - English - Department of Health (Therapeutic Goods Administration)

rhophylac 1500iu human anti-d immunoglobulin solution for injection syringe

csl behring australia pty ltd - anti-d rho immunoglobulin, quantity: 1500 iu - injection, solution - excipient ingredients: chloride; glycine; sodium; albumin - prevention of rh sensitisation in rh(d)-negative females at or below child-bearing age and treatment of rh(d)-negative persons after incompatible transfusions of rh(d)-positive blood or other products containing red blood cells.

BETASERON POWDER FOR SOLUTION Canada - English - Health Canada

betaseron powder for solution

bayer inc - interferon beta-1b - powder for solution - 0.3mg - interferon beta-1b 0.3mg - immunomodulatory agents

CHANTIX- varenicline tartrate tablet, film coated United States - English - NLM (National Library of Medicine)

chantix- varenicline tartrate tablet, film coated

avera mckennan hospital - varenicline tartrate (unii: 82269asb48) (varenicline - unii:w6hs99o8zo) - varenicline 0.5 mg - chantix is indicated for use as an aid to smoking cessation treatment. chantix is contraindicated in patients with a known history of serious hypersensitivity reactions or skin reactions to chantix. risk summary available human data on the use of chantix in pregnant women are not sufficient to inform a drug associated risk. smoking during pregnancy is associated with maternal, fetal, and neonatal risks [see clinical considerations] . in animal studies, varenicline did not result in major malformations but caused decreased fetal weights in rabbits when dosed during organogenesis at exposures equivalent to 50 times the exposure at the maximum recommended human dose (mrhd). additionally, administration of varenicline to pregnant rats during organogenesis through lactation produced developmental toxicity in offspring at maternal exposures equivalent to 36 times human exposure at the mrhd [see data] . the estimated background risk of oral clefts is increased by approximately 30% in infants of women who smoke durin

CHANTIX- varenicline tartrate kit United States - English - NLM (National Library of Medicine)

chantix- varenicline tartrate kit

a-s medication solutions - varenicline tartrate (unii: 82269asb48) (varenicline - unii:w6hs99o8zo) - varenicline 0.5 mg - chantix is indicated for use as an aid to smoking cessation treatment. chantix is contraindicated in patients with a known history of serious hypersensitivity reactions or skin reactions to chantix. risk summary available data have not suggested an increased risk for major birth defects following exposure to varenicline in pregnancy, compared with women who smoke [see data]. smoking during pregnancy is associated with maternal, fetal, and neonatal risks (see clinical considerations) . in animal studies, varenicline did not result in major malformations but caused decreased fetal weights in rabbits when dosed during organogenesis at exposures equivalent to 50 times the exposure at the maximum recommended human dose (mrhd). additionally, administration of varenicline to pregnant rats during organogenesis through lactation produced developmental toxicity in offspring at maternal exposures equivalent to 36 times human exposure at the mrhd [see data] . the estimated background risk of oral clefts is increased by

CHANTIX- varenicline tartrate tablet, film coated United States - English - NLM (National Library of Medicine)

chantix- varenicline tartrate tablet, film coated

aphena pharma solutions - tennessee, llc - varenicline tartrate (unii: 82269asb48) (varenicline - unii:w6hs99o8zo) - varenicline 1 mg - chantix is indicated for use as an aid to smoking cessation treatment. chantix is contraindicated in patients with a known history of serious hypersensitivity reactions or skin reactions to chantix. risk summary available human data on the use of chantix in pregnant women are not sufficient to inform a drug associated risk. smoking during pregnancy is associated with maternal, fetal, and neonatal risks [see clinical considerations] . in animal studies, varenicline did not result in major malformations but caused decreased fetal weights in rabbits when dosed during organogenesis at exposures equivalent to 50 times the exposure at the maximum recommended human dose (mrhd). additionally, administration of varenicline to pregnant rats during organogenesis through lactation produced developmental toxicity in offspring at maternal exposures equivalent to 36 times human exposure at the mrhd [see data] . the estimated background risk of oral clefts is increased by approximately 30% in infants of women who smoke durin

CHANTIX- varenicline tartrate tablet, film coated United States - English - NLM (National Library of Medicine)

chantix- varenicline tartrate tablet, film coated

proficient rx lp - varenicline tartrate (unii: 82269asb48) (varenicline - unii:w6hs99o8zo) - chantix is indicated for use as an aid to smoking cessation treatment. chantix is contraindicated in patients with a known history of serious hypersensitivity reactions or skin reactions to chantix. risk summary available data have not suggested an increased risk for major birth defects following exposure to varenicline in pregnancy, compared with women who smoke [see data]. smoking during pregnancy is associated with maternal, fetal, and neonatal risks (see clinical considerations) . in animal studies, varenicline did not result in major malformations but caused decreased fetal weights in rabbits when dosed during organogenesis at exposures equivalent to 50 times the exposure at the maximum recommended human dose (mrhd). additionally, administration of varenicline to pregnant rats during organogenesis through lactation produced developmental toxicity in offspring at maternal exposures equivalent to 36 times human exposure at the mrhd [see data] . the estimated background risk of oral clefts is increased by

LACTACLOX LC LACTATING COW INTRAMAMMARY ANTIBIOTIC INFUSION Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

lactaclox lc lactating cow intramammary antibiotic infusion

norbrook laboratories australia pty limited - ampicillin as the sodium salt; cloxacillin as sodium monohydrate salt - misc. intra mammary - ampicillin as the sodium salt antibiotic active 75.0 mg/5gsyr; cloxacillin as sodium monohydrate salt antibiotic active 200.0 mg/5gsyr - antibiotic & related - dairy cattle lactating | bovine | milking cow - antibiotic - anti-infective | antibiotics - oral, parenteral | arcanobacterium spp. | bacterial infection | corynebacterium spp. | escherichia coli (e. coli) | mastitis | organisms sensitive to cloxacillin | staphylococcus spp. | streptococcus agalactiae | streptococcus spp. | abrasions | abscesses | airsacculitis | amoxycillin sensitive bacteria | anaerobic bacterial infection | antiseptic | associated with viral disease | avian mycoplasmas | bacterial canker | blackhead | body odours | bowed tendons | broad spectrum | burns | clavulanic acid sensitive | coccidiosis | coliform complex | conjunctivitis | coryza | cowpox | cracks | crd | crusts | dandruff | dermatological disorders | dermatoses | dermatosis | diarrhoea | dry skin | dysentery | eczema | endometritis | enteric diseases | enteritis | enzootic pneumonia | escherichia coli | european brood disease | feed efficiency | fungal infections | gentamicin sensitive | girth galls | gram negative organisms | gram positive organisms | hypermotility | includin

TETRAVET 980 SOLUBLE ANTIBIOTIC POWDER Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

tetravet 980 soluble antibiotic powder

elanco australasia pty ltd - oxytetracycline hydrochloride - oral powder, pre-mix - oxytetracycline hydrochloride antibiotic active 980.0 mg/g - antibiotic & related - animal feeder / waterer | calf | cattle | pigs | poultry | beef | beef calf | boar | bos indicus | bos taurus | bovine | breeder - antibiotics - oral, parenteral | airsacculitis | amoxycillin sensitive bacteria | anaerobic bacterial infection | avian mycoplasmas | clavulanic acid sensitive | coccidiosis | coryza | crd | dermatoses | diarrhoea | endometritis | enteritis | enzootic pneumonia | escherichia coli | european brood disease | gentamicin sensitive | hypermotility | infected wounds | infections | lactating | mastitis | protozoal infections | pyometra | salmonellosis | sinusitis | systemic bacterial infection